Skip to main content
Download PDF

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

Hereditary Cancer in Clinical Practice volume 16, Article number: 10 (2018) Cite this article

The Original Article was published on 13 November 2017

Retraction

This article [1] has been retracted at the request of the authors. Upon re-review of the data, the authors identified coding errors in this study. Due to an error in the SQL query, the conclusions drawn in the article are incorrect. A re-examination of the data shows that there is no association between familial breast cancer and the BRCA2 variant c.68–7 T > A. Another recent study suggests that the variant is not pathogenic [2]. All authors agree to this retraction.

References

  1. Møller P, et al. The BRCA2 variant c.68-7 T>a is associated with breast cancer. Hered Cancer Clin Pract. 2017;15:20.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Colombo M, et al. The BRCA2 c.68-7T > a variant is not pathogenic: a model for clinical calibration of spliceogenicity. Hum Mutat. 2018;39:729–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Genetics, Research Group Inherited Cancer, Oslo University Hospital, Oslo, Norway

    Pål Møller

  2. Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

    Pål Møller & Eivind Hovig

  3. Center for Hereditary Tumors, HELIOS-Klinikum Wuppertal, University of Witten-Herdecke, Wuppertal, Germany

    Pål Møller

  4. Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

    Eivind Hovig

  5. Department of Informatics, University of Oslo, Oslo, Norway

    Eivind Hovig

Authors
  1. Pål Møller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eivind Hovig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pål Møller.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Møller, P., Hovig, E. Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer. Hered Cancer Clin Pract 16, 10 (2018). https://doi.org/10.1186/s13053-018-0093-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13053-018-0093-1

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287